241 related articles for article (PubMed ID: 21487942)
1. Chronological change of antibiotic use and antibiotic resistance in Escherichia coli causing urinary tract infections.
Shigemura K; Tanaka K; Adachi M; Yamashita M; Arakawa S; Fujisawa M
J Infect Chemother; 2011 Oct; 17(5):646-51. PubMed ID: 21487942
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
3. Does urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli show same antibiotic resistance when it recurs?
Ahn ST; Kim SW; Kim JW; Park HS; Moon DG; Oh MM
J Infect Chemother; 2019 Jul; 25(7):498-502. PubMed ID: 30852104
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
5. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
[TBL] [Abstract][Full Text] [Related]
6. [Current antibiotic resistance profile of uropathogenic Escherichia coli strains and therapeutic consequences].
El Bouamri MC; Arsalane L; Kamouni Y; Yahyaoui H; Bennouar N; Berraha M; Zouhair S
Prog Urol; 2014 Dec; 24(16):1058-62. PubMed ID: 25310915
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of antibiotic treatments for urinary tract infections in the elderly, especially regarding the effect on extended spectrum β-lactamase producing (ESBL-) Escherichia coli: A comparison between meropenem and alternatives].
Yamamoto A; Yamasaki K
Nihon Ronen Igakkai Zasshi; 2015; 52(2):153-61. PubMed ID: 25994987
[TBL] [Abstract][Full Text] [Related]
8. Childhood urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and empiric therapy.
Uyar Aksu N; Ekinci Z; Dündar D; Baydemir C
Pediatr Int; 2017 Feb; 59(2):176-180. PubMed ID: 27501161
[TBL] [Abstract][Full Text] [Related]
9. Virulence Genes and Antibiotic Susceptibilities of Uropathogenic E. coli Strains.
Uzun C; Oncül O; Gümüş D; Alan S; Dayioğlu N; Küçüker MA
Clin Lab; 2015; 61(8):941-50. PubMed ID: 26427137
[TBL] [Abstract][Full Text] [Related]
10. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
[TBL] [Abstract][Full Text] [Related]
11. Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Cho SY; Choi SM; Park SH; Lee DG; Choi JH; Yoo JH
Korean J Intern Med; 2016 Jan; 31(1):156-61. PubMed ID: 26767869
[TBL] [Abstract][Full Text] [Related]
12. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
[TBL] [Abstract][Full Text] [Related]
13. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
[TBL] [Abstract][Full Text] [Related]
14. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA
BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
16. The importance of gender-stratified antibiotic resistance surveillance of unselected uropathogens: a Dutch Nationwide Extramural Surveillance study.
den Heijer CD; Penders J; Donker GA; Bruggeman CA; Stobberingh EE
PLoS One; 2013; 8(3):e60497. PubMed ID: 23555983
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
[TBL] [Abstract][Full Text] [Related]
18. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
19. International Comparison of Causative Bacteria and Antimicrobial Susceptibilities of Urinary Tract Infections between Kobe, Japan, and Surabaya, Indonesia.
Kitagawa K; Shigemura K; Yamamichi F; Alimsardjono L; Rahardjo D; Kuntaman K; Shirakawa T; Fujisawa M
Jpn J Infect Dis; 2018 Jan; 71(1):8-13. PubMed ID: 29093320
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli.
Abe Y; Inan-Erdogan I; Fukuchi K; Wakabayashi H; Ogawa Y; Hibino S; Sakurai S; Matsuhashi K; Watanabe Y; Hashimoto K; Ugajin K; Itabashi K
J Infect Chemother; 2017 Aug; 23(8):517-522. PubMed ID: 28528936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
